Evidence map›Paper›PMID 35064366›Full record

Trial reportOral and maxillofacial surgery2022

NSAID chronotherapy after impacted third molar extraction: a randomized controlled trial.

Zaid Tamimi, Mohammad Abusamak, Haider Al-Waeli, Mohammad Al-Tamimi, Rola Al Habashneh, Mohammad Ghanim, Mohammed Al-Nusair, Qiman Gao, Belinda Nicolau, Faleh Tamimi

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Oral and maxillofacial surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Zaid TamimiFaculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan. zztamimi@just.edu.jo.
Mohammad AbusamakFaculty of Dentistry, McGill University, Montreal, QC, Canada.
Haider Al-WaeliFaculty of Dentistry, Dalhousie University, Halifax, NS, Canada.
Mohammad Al-TamimiFaculty of Dentistry, McGill University, Montreal, QC, Canada.
Rola Al HabashnehFaculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.
Mohammad GhanimFaculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.
Mohammed Al-NusairFaculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Qiman GaoFaculty of Dentistry, McGill University, Montreal, QC, Canada.
Belinda NicolauFaculty of Dentistry, McGill University, Montreal, QC, Canada.
Faleh TamimiCollege of Dental Medicine, Qatar University, Doha, Qatar.
Jordan University of Science and Technology · JOMcGill University · CADalhousie University · CAQatar University · QA

Funding

Jordan University of Science and Technology 20170307
6 · The paper itself

Abstract

objectivesPostoperative pain management impacts patients' quality of life and morbidity. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are widely used for this following a 3-doses-per-day regime. However, pain and inflammation follow a circadian rhythm, and animal models assessing the scheduling of NSAID administration (e.g., chronotherapy) have shown that while their use during the active phase of the day enhances postoperative recovery, their administration during the resting phase could have detrimental effects. This observation has led us to hypothesize that night administration of NSAID might be unnecessary in post-surgical scenarios. Therefore, a randomized clinical trial was conducted to test this hypothesis in surgical third molar extractions. MATERIALS AND

methodsSeventy (18-35 years) healthy participants requiring surgical removal of impacted lower third molars were recruited and randomized into a double-blind placebo-controlled study. For three days postoperatively, the treatment group (n = 33) received ibuprofen (400 mg) at 8 AM, 1 PM, and a placebo at 8 PM, while the control group (n = 37) received ibuprofen (400 mg) at 8 AM, 1 PM, and 8 PM. Pain severity was assessed by visual analog scale (VAS) and healing indicators including facial swelling, mouth opening, and C-reactive protein blood levels were also measured.

resultsPain VAS measures showed a circadian variation peaking at night. Also, no significant differences were observed between the two groups of the study in terms of postoperative pain scores (estimate: 0.50, 95% CI = [- 0.38, 1.39]) or any other healing indicator.

conclusionsPostoperative pain follows a circadian rhythm. Moreover, night administration of ibuprofen might not provide any significant benefits in terms of pain management and control of inflammation, and two doses during the day only could be sufficient for pain management after surgical interventions. KNOWLEDGE TRANSFER STATEMENT: Even though this study cannot rule out the possibility that a reduced regime is different than a standard regime, nocturnal doses of ibuprofen seem to have no clinical significance in the short term, and the results of this study provide evidence in favor of reducing ibuprofen administration from three doses to two doses only after third molar surgery.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalTooth, ImpactedChronotherapyDouble-Blind MethodHumansIbuprofenInflammationPostoperative PainQuality of LifeTooth ExtractionAnti-Inflammatory Agents, Non-SteroidalIbuprofenChronotherapyDrug chronotherapyMolarNSAIDsPain managementThirdTooth extraction

Identifiers

PMID35064366
OpenAlexW4207023620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.